Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1982-03-26
1985-06-11
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544284, 544285, 544286, 544287, 546184, 546192, 546193, 546201, 546207, 546212, 546242, 546245, 546246, 546248, A61K 31505, C07D40114
Patent
active
045229457
ABSTRACT:
Novel quinazoline derivatives, comprising in the heterocyclic part of their quinazoline nucleus at least one carbonyl or thiocarbonyl group and a particularly substituted piperidinyl-alkyl side chain, said compounds being potent serotonin-antagonists.
REFERENCES:
patent: 3322766 (1967-05-01), Schipper
patent: 3635976 (1972-01-01), Shetty
patent: 4096144 (1978-06-01), Yamamoto et al.
patent: 4099002 (1978-07-01), Inaba et al.
patent: 4146717 (1979-03-01), Yamamoto et al.
Kennis Ludo
Van der Aa Marcel
Van Heertum Albert
Vandenberk Jan
Dellenbaugh Geoffrey G.
Hollrah Glennon H.
Janssen Pharmaceutica N.V.
Turnipseed James H.
LandOfFree
(Piperidinylalkyl) quinazoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (Piperidinylalkyl) quinazoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (Piperidinylalkyl) quinazoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1183601